We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $22.1B
1-Year Est. Return 45.54%
This Fund
S&P 500
This Quarter Est. Return
+9.12%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
–
AUM
$13.2B
AUM Growth
+$1.19B
Cap. Flow
+$398M
Cap. Flow %
3.01%
Top 10 Hldgs %
25.15%
Holding
2,888
New
90
Increased
233
Reduced
1,480
Closed
57

Top Buys

Rank Stock Value
1
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$651M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$24.1M
3
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$19.4M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$17.9M
5
MUB icon
iShares National Muni Bond ETF
MUB
+$8.93M

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$33.4M
2
AAPL icon
Apple
AAPL
+$20.4M
3
MSFT icon
Microsoft
MSFT
+$10.9M
4
TWTR
Twitter, Inc.
TWTR
+$9.15M
5
Y
Alleghany Corp
Y
+$7.32M

Sector Composition

Rank Sector Weight
1 Technology 19.63%
2 Healthcare 13.34%
3 Financials 12.1%
4 Consumer Discretionary 9.16%
5 Industrials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZM icon
1426
Zoom
ZM
$30.8B
$697K 0.01%
10,285
-190
-2% -$14.4K
XYZ
1427
Block Inc
XYZ
$49.9B
$697K 0.01%
11,085
+215
+2% +$13.3K
BUSE icon
1428
First Busey Corp
BUSE
$2.58B
$696K 0.01%
28,143
+550
+2% +$13.8K
PPC icon
1429
Pilgrim's Pride
PPC
$6.4B
$695K 0.01%
29,285
-943
-3% -$22.5K
KDNY
1430
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$694K 0.01%
26,495
– –
CHCO icon
1431
City Holding Co
CHCO
$2.08B
$693K 0.01%
7,440
– –
TEVA icon
1432
Teva Pharmaceuticals
TEVA
$42.6B
$691K 0.01%
75,753
– –
FBK icon
1433
FB Financial Corp
FBK
$3.1B
$689K 0.01%
19,074
– –
STEM icon
1434
Stem
STEM
$55.9M
$688K 0.01%
3,848
– –
PATK icon
1435
Patrick Industries
PATK
$2.79B
$688K 0.01%
17,024
-1,735
-9% -$60.3K
BBT
1436
Beacon Financial Corp
BBT
$2.71B
$685K 0.01%
22,916
– –
TVTX icon
1437
Travere Therapeutics
TVTX
$5.79B
$684K 0.01%
32,507
– –
GNL icon
1438
Global Net Lease
GNL
$1.9B
$683K 0.01%
54,350
– –
VRTS icon
1439
Virtus Investment Partners
VRTS
$1.12B
$683K 0.01%
3,566
-321
-8% -$57.4K
AVNS
1440
DELISTED
Avanos Medical
AVNS
$682K 0.01%
25,214
– –
DASH icon
1441
DoorDash
DASH
$93.7B
$682K 0.01%
13,966
-349
-2% -$18.1K
AROC icon
1442
Archrock
AROC
$5.84B
$681K 0.01%
75,819
– –
PRAA icon
1443
PRA Group
PRAA
$762M
$681K 0.01%
20,146
– –
XPEL icon
1444
XPEL
XPEL
$1.35B
$680K 0.01%
11,323
-349
-3% -$22.3K
GEO icon
1445
The GEO Group
GEO
$4.14B
$679K 0.01%
61,969
– –
EVRI
1446
DELISTED
Everi Holdings
EVRI
$678K 0.01%
47,250
– –
OCFC icon
1447
OceanFirst Financial
OCFC
$1.85B
$677K 0.01%
31,851
– –
KTOS icon
1448
Kratos Defense & Security Solutions
KTOS
$11.8B
$676K 0.01%
65,490
– –
UVV icon
1449
Universal Corp
UVV
$1.13B
$676K 0.01%
12,796
– –
CXW icon
1450
CoreCivic
CXW
$3.32B
$674K 0.01%
58,327
-5,223
-8% -$58K
56 57
58
59 60

Similar funds

BA
Bridgewater Associates Westport, Connecticut $22.4B AUM 34.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

MetLife Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, MetLife Investment Management held 2,888 positions worth $13.2B, up 9.9% from $12B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management deployed $398M of net new capital in Q4 2022, opening 90 new positions and adding to 233 existing holdings. Its largest new stake was Atlassian: 8,691 shares worth $1.12M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $33.4M trimmed.

  • MetLife Investment Management's largest Q4 2022 buy was Atlassian: 8,691 shares worth $1.12M.
  • MetLife Investment Management added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2022, an estimated $651M increase.
  • MetLife Investment Management's biggest Q4 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $33.4M.
  • MetLife Investment Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $9.15M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $13.2B portfolio in Q4 2022.
  • MetLife Investment Management opened 90 new positions and closed 57 in Q4 2022.
  • MetLife Investment Management's portfolio value rose 9.9% quarter-over-quarter to $13.2B.

Based on MetLife Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.